Tinlarebant (LBS-008)

Stargardt disease type 1

Manufacturer: Belite Bio
Regulatory submission: NDA submitted June 2026
Launch: Anticipated in March 2027
Last updated: September 19, 2026

Section

Product information and disease description Product description Product information

Drug/Drug, drug/disease interactions

3 evidence topics · 1 source

Effects of Tinlarebant on other drugs

No evidence found.